The trajectory of companies tied to the drug's legacy presents a intricate investment scenario . While the initial surge generated substantial gains, generic alternatives have significantly eroded sales . https://socialioapp.com/story6505948/copyright-s-flagship-product-and-pharma-a-speculative-investment